We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $43.3B
1-Year Est. Return 29.3%
This Fund
S&P 500
This Quarter Est. Return
+17.09%
1 Year Est. Return
+29.3%
3 Year Est. Return
+83.12%
5 Year Est. Return
+90.93%
10 Year Est. Return
+282.52%
AUM
$43.3B
AUM Growth
+$4.47B
Cap. Flow
-$120M
Cap. Flow %
-0.28%
Top 10 Hldgs %
19.72%
Holding
4,210
New
286
Increased
1,913
Reduced
1,499
Closed
436

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 4.34%
3 Industrials 3.63%
4 Consumer Discretionary 3.11%
5 Communication Services 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRE icon
1451
CareTrust REIT
CTRE
$10B
$2.33M 0.01%
57,789
-1,598
-3% -$62.8K
ABEV icon
1452
Ambev
ABEV
$47.9B
$2.33M 0.01%
742,098
-18,710
-2% -$58.5K
IBDW icon
1453
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.49B
$2.33M 0.01%
111,633
+27,422
+33% +$572K
NN icon
1454
NextNav
NN
$1.79B
$2.33M 0.01%
130,462
-16,790
-11% -$325K
RITM icon
1455
Rithm Capital
RITM
$5.58B
$2.32M 0.01%
246,766
+7,384
+3% +$70.4K
TATT icon
1456
TAT Technologies
TATT
$527M
$2.32M 0.01%
48,023
+10,879
+29% +$437K
RWK icon
1457
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.32B
$2.31M 0.01%
15,816
-887
-5% -$124K
EMN icon
1458
Eastman Chemical
EMN
$7.69B
$2.3M 0.01%
34,398
+1,914
+6% +$140K
BIBL icon
1459
Inspire 100 ETF
BIBL
$474M
$2.3M 0.01%
39,712
-7,756
-16% -$414K
IWC icon
1460
iShares Micro-Cap ETF
IWC
$1.42B
$2.29M 0.01%
11,450
-16,971
-60% -$3.11M
BBIO icon
1461
BridgeBio Pharma
BBIO
$16.4B
$2.29M 0.01%
30,727
+1,668
+6% +$117K
DES icon
1462
WisdomTree US SmallCap Dividend Fund
DES
$2.19B
$2.28M 0.01%
56,120
+2,177
+4% +$83.9K
RLY icon
1463
State Street Multi-Asset Real Return ETF
RLY
$1.26B
$2.28M 0.01%
66,015
+14,935
+29% +$543K
QVOY
1464
Q3 All-Season Active Rotation ETF
QVOY
$58.5M
$2.28M 0.01%
73,574
+15,654
+27% +$467K
NFJ
1465
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.39B
$2.27M 0.01%
149,757
+99,789
+200% +$1.43M
UAMY icon
1466
United States Antimony
UAMY
$728M
$2.27M 0.01%
313,376
+3,596
+1% +$32.5K
HR icon
1467
Healthcare Realty
HR
$7.56B
$2.27M 0.01%
112,718
-3,945
-3% -$76.6K
BUD icon
1468
AB InBev
BUD
$164B
$2.27M 0.01%
27,583
-21,300
-44% -$1.68M
FEOE
1469
First Eagle Overseas Equity ETF
FEOE
$1.55B
$2.27M 0.01%
42,523
+11,809
+38% +$628K
PEY icon
1470
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.16B
$2.27M 0.01%
97,827
-5,874
-6% -$131K
TWLO icon
1471
Twilio
TWLO
$28.6B
$2.27M 0.01%
10,993
-5,377
-33% -$953K
EVTR icon
1472
Eaton Vance Total Return Bond ETF
EVTR
$5.64B
$2.27M 0.01%
44,702
+14,720
+49% +$749K
DINO icon
1473
HF Sinclair
DINO
$16.2B
$2.27M 0.01%
32,528
+2,671
+9% +$178K
IDXX icon
1474
Idexx Laboratories
IDXX
$44.9B
$2.26M 0.01%
4,300
-246
-5% -$138K
QFLR icon
1475
Innovator Nasdaq-100 Managed Floor ETF
QFLR
$509M
$2.26M 0.01%
62,073
-838
-1% -$29.7K

Similar funds

Cambridge Investment Research Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Cambridge Investment Research Advisors held 4,210 positions worth $43.3B, up 12% from $38.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q2 2026 filing shows 286 new, 1,913 increased, 1,499 reduced and 436 closed positions. Its largest new stake was SpaceX: 259,405 shares worth $44.3M. The largest sale was FT Vest Fund of Buffer ETFs, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Cambridge Investment Research Advisors's largest Q2 2026 buy was SpaceX: 259,405 shares worth $44.3M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2026, an estimated $126M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2026 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $73.5M.
  • Cambridge Investment Research Advisors fully exited FT Vest Fund of Buffer ETFs in Q2 2026, selling an estimated $111M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $43.3B portfolio in Q2 2026.
  • Cambridge Investment Research Advisors opened 286 new positions and closed 436 in Q2 2026.
  • Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $43.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.